European Heart Journal

Hopes dashed for an agent to prevent reperfusion injury

The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective ...

1 hour ago
popularity not rated yet | comments 0